November 18, 2025
A Delaware federal jury was wrong when it determined that Johnson & Johnson subsidiary DePuy Synthes should pay RSB Spine $12 million for infringing spinal fusion patents under the doctrine of equivalents, DePuy said Monday.
August 28, 2025
Johnson & Johnson unit DePuy Synthes Sales Inc. could not persuade a Delaware federal judge that it invented the technology behind an RSB Spine LLC spinal fusion surgery patent a jury says it owes $12 million for infringing.
December 09, 2022
A Delaware federal jury on Friday found that Johnson & Johnson unit DePuy Synthes Sales Inc. infringed a spinal fusion surgery patent under the doctrine of equivalents and owed $12 million to RSB Spine LLC.
November 22, 2022
A Delaware federal judge Tuesday invalidated one of the two spinal fusion surgery patents that Johnson & Johnson unit DePuy Synthes Sales Inc. is accused of infringing less than two weeks before the scheduled start of a trial.